Hafez Mona H, El-Mougy Fatma A F, Makar Samuel H, Abd El Shaheed Semon
Department of Pediatric Nephrology, Cairo University, Egypt.
Iran J Kidney Dis. 2015 Mar;9(2):126-31.
Diabetic nephropathy is a major cause of morbidity and mortality among young adults with type 1 diabetes mellitus (DM). Albuminuria, the gold standard for early diagnosis, cannot always detect early diabetic nephropathy. We aimed at evaluating the level of urine neutrophil gelatinase-associated lipocalin (NGAL) as a marker of tubulointerstitial damage in children and adolescents with type 1 DM in relation to the level of albuminuria and other parameters.
Fifty children with type 1 DM for more than 5 years were included in this study (mean age, 13.8 ± 4.0 years), and 18 healthy children served as controls. Patients with overt albuminuria (> 300 mg/g creatinine) or inflammatory states were excluded. Urine NGAL, microalbuminuria, and urine albumin-creatinine ratio were measured in patients and controls as well as other parameters.
Urine NGAL was significantly higher in microalbuminuric in comparison with normoalbuminuric patients and controls, and correlated positively with urine albumin-creatinine ratio. A positive urine NGAL was observed in 12 of 38 normoalbuminuric patients (31.6%) compared to 9 of 12 microalbuminuric patients (75%). A positive correlation was reported between urine NGAL and both Hemoglobin A1c and duration of DM, but not with estimated glomerular filtration rate or hypertension.
Diabetic children, even some normoalbuminurics, showed increased urine NGAL. This finding may support the hypothesis of a "tubular phase" of diabetic disease preceding overt diabetic nephropathy, and hence, the use of urine NGAL measurement for early evaluation of renal involvement.
糖尿病肾病是1型糖尿病(DM)青年患者发病和死亡的主要原因。蛋白尿作为早期诊断的金标准,并不总能检测出早期糖尿病肾病。我们旨在评估尿中性粒细胞明胶酶相关脂质运载蛋白(NGAL)水平,作为1型糖尿病儿童和青少年肾小管间质损伤的标志物,并将其与蛋白尿水平及其他参数进行关联研究。
本研究纳入了50例病程超过5年的1型糖尿病患儿(平均年龄13.8±4.0岁),并选取18例健康儿童作为对照。排除明显蛋白尿(>300mg/g肌酐)或处于炎症状态的患者。对患者和对照进行尿NGAL、微量白蛋白尿及尿白蛋白肌酐比值的检测,同时检测其他参数。
微量白蛋白尿患者的尿NGAL水平显著高于正常白蛋白尿患者及对照,且与尿白蛋白肌酐比值呈正相关。38例正常白蛋白尿患者中有12例(31.6%)尿NGAL呈阳性,而12例微量白蛋白尿患者中有9例(75%)呈阳性。尿NGAL与糖化血红蛋白及糖尿病病程均呈正相关,但与估计肾小球滤过率或高血压无关。
糖尿病患儿,即使是一些正常白蛋白尿患儿,尿NGAL水平也会升高。这一发现可能支持糖尿病肾病显性病变之前存在“肾小管期”的假说,因此,尿NGAL检测可用于早期评估肾脏受累情况。